[1] Capel B, Swain A, Nicolis S, et al. Circular transcripts of the testis-determining gene Sry in adult mouse testis [J]. Cell, 1993, 73(5): 1019-1030.
[2] Esteller M. Non-coding RNAs in human disease [J]. Nat Rev Genet, 2011, 12(12): 861-874.
[3] Johnsson P, Lipovich L, Grander D, et al. Evolutionary conservation of long non-coding RNAs; sequence, structure, function [J]. Biochim Biophys Acta, 2014, 1840(3): 1063-1071.
[4] Rinn J L, Kertesz M, Wang J K, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs [J]. Cell, 2007, 129(7): 1311-1323.
[5] Feng J, Bi C, Clark B S, et al. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator [J]. Genes Dev, 2006, 20(11): 1470-1484.
[6] Beltran M, Puig I, Pena C, et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition [J]. Genes Dev, 2008, 22(6): 756-769.
[7] Willingham A T, Orth A P, Batalov S, et al. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT [J]. Science, 2005, 309(5740): 1570-1573.
[8] Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency [J]. Nature, 2013, 495(7441): 333-338.
[9] Hansen T B, Jensen T I, Clausen B H, et al. Natural RNA circles function as efficient microRNA sponges [J]. Nature, 2013, 495(7441): 384-388.
[10] Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus [J]. Nat Struct Mol Biol, 2015, 22(3): 256-264.
[11] Ashwal-Fluss R, Meyer M, Pamudurti N R, et al. circRNA biogenesis competes with premRNA splicing [J]. Mol Cell, 2014, 56(1): 55-66.
[12] Zhang P, Kang J Y, Gou L T, et al. MIWI and piRNA-mediated cleavage of messenger RNAs in mouse testes [J]. Cell Res, 2015, 25(2): 193-207.
[13] Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deepsequencing data [J]. Nucleic Acids Res, 2011, 39: D152-D157.
[14] Jiang Q, Wang Y, Hao Y, et al. miR2Disease: a manually curated database for microRNA deregulation in human disease [J]. Nucleic Acids Res, 2009, 37: D98-D104.
[15] Small E M, Olson E N. Pervasive roles of microRNAs in cardiovascular biology [J]. Nature, 2011, 469(7330): 336-342.
[16] Thum T, Condorelli G. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology [J]. Circ Res, 2015, 116(4): 751-762.
[17] Van Rooij E, Sutherland L B, Qi X, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA [J]. Science, 2007, 316(5824): 575-579.
[18] Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy [J]. Nat Med, 2007, 13(5): 613-618.
[19] Van Rooij E, Sutherland L B, Thatcher J E, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis [J]. Proc Natl Acad Sci USA,
2008, 105(35): 13027-13032.
[20] Karakikes I, Chaanine A H, Kang S, et al. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling [J]. J Am Heart Assoc, 2013, 2(2): e000078.
[21] Lorenzen J M, Schauerte C, Hubner A, et al. Osteopontin is indispensible for AP1-mediated angiotensinⅡ-related miR-21 transcription during cardiac fibrosis [J]. Eur Heart J, 2015, 36(32): 2184-2196.
[22] Duisters R F, Tijsen A J, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling [J]. Circ Res, 2009, 104(2): 170-178.
[23] Bernardo B C, Gao X M, Winbanks C E, et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function [J]. Proc Natl Acad Sci USA, 2012, 109(43): 17615-17620.
[24] Pan Z, Sun X, Shan H, et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factorbeta1 pathway [J]. Circulation, 2012, 126(7): 840-850.
[25] Wei L, Yuan M, Zhou R, et al. MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a [J]. J Cardiovasc Pharmacol, 2015, 65(4): 357-363.
[26] Seok H Y, Chen J, Kataoka M, et al. Loss of microRNA-155 protects the heart from pathological cardiac hypertrophy [J]. Circ Res, 2014, 114(10): 1585-1595.
[27] Yang Y, Del Re D P, Nakano N, et al. miR-206 mediates YAP-induced cardiac hypertrophy and survival [J]. Circ Res, 2015, 117(10): 891-904.
[28] Ucar A, Gupta S K, Fiedler J, et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy [J]. Nat Commun, 2012, 3: 1078.
[29] Liu F, Li N, Long B, et al. Cardiac hypertrophy is negatively regulated by miR-541 [J]. Cell Death Dis, 2014, 5: e1171.
[30] Wang K, Liu F, Zhou L Y, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489 [J]. Circ Res, 2014, 114(9): 1377-1388.
[31] Wilkins B J, Dai Y S, Bueno O F, et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy [J]. Circ Res, 2004, 94(1): 110-118.
[32] Molkentin J D, Lu J R, Antos C L, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy [J]. Cell, 1998, 93(2): 215-228.
[33] Kehat I, Molkentin J D. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation [J]. Circulation, 2010, 122(25): 2727-2735.
[34] Hunter J J, Chien K R. Signaling pathways for cardiac hypertrophy and failure [J]. N Engl J Med, 1999, 341(17): 1276-1283.
[35] Lin Z, Murtaza I, Wang K, et al. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy [J]. Proc Natl Acad Sci USA, 2009, 106(29): 12103-12108.
[36] Wang K, Long B, Zhou J, et al. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy [J]. J Biol Chem, 2010, 285(16): 11903-11912.
[37] Wang J X, Jiao J Q, Li Q, et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 [J]. Nat Med, 2011, 17(1): 71-78.
[38] Wang J X, Zhang X J, Li Q, et al. MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD [J]. Circ Res, 2015, 117(4):
352-363.
[39] ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome [J]. Nature, 2012, 489(7414): 57-74.
[40] Han P, Li W, Lin C H, et al. A long noncoding RNA protects the heart from pathological hypertrophy [J]. Nature, 2014, 514(7520): 102-106.
[41] Wang K, Liu C Y, Zhou L Y, et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p [J]. Nat Commun, 2015, 6: 6779.
[42] Wang K, Long B, Zhou L Y, et al. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation [J]. Nat Commun, 2014, 5: 3596.
[43] Viereck J, Kumarswamy R, Foinquinos A, et al. Long noncoding RNA Chast promotes
cardiac remodeling [J]. Sci Transl Med, 2016, 8(326): 326ra322.
[44] Burd C E, Jeck W R, Liu Y, et al. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk [J]. PLoS Genet,
2010, 6(12): e1001233.
[45] Wang K, Long B, Liu F, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223 [J]. Eur Heart J, 2016, pii: ehv713.
[46] Du W W, Yang W, Chen Y, et al. Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses [J]. Eur Heart J, 2016, pii: ehw001.
[47] Wang J X, Gao J, Ding S L, et al. Oxidative modification of miR-184 enables it to target Bcl-xL and Bcl-w [J]. Mol Cell, 2015, 59(1): 50-61. |